IL-27+ Bregs have been reported to be upregulated and associated with more aggressive diseases in patients with colorectal adenocarcinoma (CRC), liver metastases from CRC, hepatocellular carcinoma (HCC), and other solid tumors. The gene discussed is IL27; the disease is hepatocellular carcinoma.